Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CNS | Common Stock | Sale | -$702K | -6.77K | -12.79% | $103.73 | 46.1K | Dec 2, 2024 | Direct | F1 |
transaction | CNS | Common Stock | Sale | -$10.4K | -100 | -0.22% | $104.18 | 46K | Dec 2, 2024 | Direct | |
transaction | CNS | Common Stock | Award | $0 | +203 | +0.44% | $0.00 | 46.2K | Dec 2, 2024 | Direct | F2 |
Id | Content |
---|---|
F1 | Represents the weighted average price. These shares were sold in a series of transactions at prices ranging from $103.18 to $104.15. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information relating to the number of shares sold at each separate price within the range set forth in this footnote. |
F2 | Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's fourth quarter 2024 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2021, January 2022, January 2023 and January 2024. |